These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1839380)

  • 1. Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1019-25. PubMed ID: 1839380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1809-15. PubMed ID: 3324962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel BM
    Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):878-87. PubMed ID: 2512132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Vink-van den Berg JC; Michel MF
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S33-40. PubMed ID: 3325928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy of ciprofloxacin, ceftazidime and gentamicin, given alone or in combination, in a model of experimental septicemia due to Klebsiella pneumoniae in neutropenic mice.
    Trautmann M; Brückner O; Marre R; Hahn H
    Infection; 1988; 16(1):49-53. PubMed ID: 3283038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berghe-van Raffe M; Michel MF
    Antimicrob Agents Chemother; 1986 Sep; 30(3):403-8. PubMed ID: 3535664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue.
    Bakker-Woudenberg IA; ten Kate MT; Stearne-Cullen LE; Woodle MC
    J Infect Dis; 1995 Apr; 171(4):938-47. PubMed ID: 7706822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebsiella pneumoniae pneumonia in rats.
    Roosendaal R; Bakker-Woudenberg IA; van den Berg JC; Michel MF
    J Infect Dis; 1985 Aug; 152(2):373-8. PubMed ID: 3897395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin.
    Schiffelers RM; Storm G; ten Kate MT; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2001 Feb; 45(2):464-70. PubMed ID: 11158742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide.
    Melissen PM; van Vianen W; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1994 Jan; 38(1):147-50. PubMed ID: 8141571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; ten Kate MT; Guo L; Working P; Mouton JW
    Antimicrob Agents Chemother; 2001 May; 45(5):1487-92. PubMed ID: 11302815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.
    Bakker-Woudenberg IA; van den Berg JC; Michel MF
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1042-50. PubMed ID: 6297384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime.
    Schiffelers RM; Storm G; ten Kate MT; Stearne-Cullen LE; den Hollander JG; Verbrugh HA; Bakker-Woudenberg IA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):369-75. PubMed ID: 11408564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia.
    Ariffin H; Navaratnam P; Mohamed M; Arasu A; Abdullah WA; Lee CL; Peng LH
    Int J Infect Dis; 2000; 4(1):21-5. PubMed ID: 10689210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.
    Leggett JE; Fantin B; Ebert S; Totsuka K; Vogelman B; Calame W; Mattie H; Craig WA
    J Infect Dis; 1989 Feb; 159(2):281-92. PubMed ID: 2644371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections.
    Levine DP; McNeil P; Lerner SA
    Am J Med; 1989 Nov; 87(5A):160S-163S. PubMed ID: 2686416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.
    Bakker-Woudenberg IA; ten Kate MT; Goessens WH; Mouton JW
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2919-25. PubMed ID: 16940082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors associated with ceftazidime-resistant Klebsiella pneumoniae infection].
    Bermejo J; Lesnaberes P; Arnesi N; Gianello M; Notario R; Borda N; Gambandé T; Bencomo B
    Enferm Infecc Microbiol Clin; 2003 Feb; 21(2):72-6. PubMed ID: 12586029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ceftazidime in experimental Klebsiella pneumoniae pneumonia: comparison with other antibiotics and measurement of its penetration into respiratory tissues and secretions.
    McColm AA; Shelley E; Ryan DM; Acred P
    J Antimicrob Chemother; 1986 Nov; 18(5):599-608. PubMed ID: 3542926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.